Search Results

ARRY Array Technologies, Inc. - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
ARRY Stock | Fundamental Analysis & Investment Insights
NASDAQ Technology Solar
Current Price Live
$6.93
Analyst Target
$10.07
+45.2% Upside
52W High
$12.23
52W Low
$3.76

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$1.06B
P/E
N/A
ROE
-19.0%
Profit margin
-4.1%
Debt/Equity
2.94
Dividend yield
N/A

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
85%
Analysis Accuracy
ARRY's deterministic health scores signal significant distress: the Piotroski F-Score of 2/9 indicates poor financial health, with weak profitability, declining revenue, and high leverage. The absence of an Altman Z-Score raises concern, as the Debt/Equity ratio of 2.94 and negative ROE (-19.02%) suggest elevated bankruptcy risk. Despite a modest Price/Sales of 0.82 and a forward P/E of 7.86, the company's -17.9% YoY revenue decline and negative profit margins undermine valuation appeal. Analysts recommend 'buy' with a $10.07 target, but this optimism appears disconnected from deteriorating fundamentals. The 52-week price range ($3.76–$12.23) and recent 1M drop of 37.6% reflect high volatility and weak market confidence.

Key Strengths

Gross margin of 25.55% indicates operational efficiency in production and cost control
Current ratio of 2.31 suggests adequate short-term liquidity to cover obligations
Price/Sales of 0.82 is below sector average, implying potential undervaluation on revenue basis
Forward P/E of 7.86 is relatively low compared to the sector average of 90.97
Insider sentiment at 40/100 reflects cautious but not outright negative sentiment

Key Risks

Piotroski F-Score of 2/9 signals severe financial distress and poor operational performance
Negative ROE (-19.02%) and ROA (4.95%) indicate inefficient use of capital and declining profitability
Debt/Equity ratio of 2.94 is dangerously high, especially for a company with negative earnings
Revenue declined 17.9% YoY, indicating shrinking market share or demand contraction
No free cash flow or operating cash flow data available, raising concerns about financial sustainability

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
27
Weak
Value
52
Future
29
Past
31
Health
22
Dividend
0
AI Verdict
weak
Key drivers: Low Piotroski F-Score (2/9), Negative revenue and earnings growth, High leverage (Debt/Equity: 2.94), Negative ROE and ROA, Lack of cash flow visibility
Confidence
88%
Value
52/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Sales of 0.82 is below sector average
  • Forward P/E of 7.86 is low relative to sector
  • Trading below 52-week high of $12.23
Watchpoints
  • No Graham Number or intrinsic value estimate available
  • Negative earnings and cash flow undermine valuation models
  • High PEG uncertainty due to missing earnings growth
Future
29/100

Ref Growth rates

Positives
  • Analyst target price of $10.07 implies upside potential
  • Some peers show strong growth (e.g., AXTI +656.5% 1Y)
Watchpoints
  • Revenue down 17.9% YoY
  • No forward earnings growth data
  • Negative operating margin (-7.90%) and profit margin (-4.07%)
  • No visible path to profitability
Past
31/100

Ref Historical trends

Positives
  • Current price ($6.93) is above 52-week low ($3.76)
  • 1-year return of +14.4% shows some recovery
Watchpoints
  • 5-year return of -80.4% reflects long-term underperformance
  • 3-year return of -64.8% indicates persistent weakness
  • 6-month return of -9.7% and 1-month drop of -37.6% show recent deterioration
Health
22/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio of 2.31 indicates short-term liquidity
  • Quick ratio of 1.37 is acceptable
Watchpoints
  • Piotroski F-Score of 2/9 is extremely low
  • No Altman Z-Score available, but Debt/Equity of 2.94 and negative ROE suggest distress
  • Negative ROE (-19.02%) and ROA (4.95%) indicate poor capital efficiency
  • No cash flow data raises sustainability concerns
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout ratio
  • Dividend strength is 0/100
  • Payout ratio is 0.00%

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.93
Analyst Target
$10.07
Upside/Downside
+45.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ARRY and closest competitors.

Updated 2026-03-13
Company 5Y 3Y 1Y 6M 1M 1W
ARRY
Array Technologies, Inc.
Primary
-80.4% -64.8% +14.4% -9.7% -37.6% +1.8%
ALNT
Allient Inc.
Peer
+77.8% +62.3% +174.1% +35.7% -5.0% -4.5%
AEHR
Aehr Test Systems, Inc.
Peer
+1246.0% +12.7% +306.3% +34.8% +5.4% +0.2%
AMPL
Amplitude, Inc.
Peer
-86.6% -40.1% -35.5% -33.6% +9.5% -6.4%
AXTI
AXT, Inc.
Peer
+47.3% +211.3% +656.5% +640.4% +15.9% -21.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
7.86
PEG Ratio
N/A
P/B Ratio
-5.13
P/S Ratio
0.82
EV/Revenue
1.59
EV/EBITDA
14.26
Market Cap
$1.06B

Profitability

Profit margins and return metrics

Profit Margin -4.07%
Operating Margin -7.9%
Gross Margin 25.55%
ROE -19.02%
ROA 4.95%

Growth

Revenue and earnings growth rates

Revenue Growth -17.9%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
2.94
High debt
Current Ratio
2.31
Strong
Quick Ratio
1.37
Good
Cash/Share
$1.6

Technology Sector Comparison

Comparing ARRY against 149 companies in the Technology sector (10 bullish, 67 neutral, 72 bearish)
Return on Equity (ROE)
-19.02%
This Stock
vs
-8.13%
Sector Avg
+134.0% (Excellent)
Profit Margin
-4.07%
This Stock
vs
-9.06%
Sector Avg
-55.1% (Weaker)
Debt to Equity
2.94
This Stock
vs
0.76
Sector Avg
+285.0% (Higher)
Revenue Growth
-17.9%
This Stock
vs
55.69%
Sector Avg
-132.1% (Slower)
Current Ratio
2.31
This Stock
vs
3.32
Sector Avg
-30.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
ARRY
Array Technologies, Inc.
BEARISH $1.06B - -19.0% -4.1% $6.93
ALNT
Allient Inc.
NEUTRAL $1.06B 55.66 7.8% 4.0% $62.34
AEHR
Aehr Test Systems, Inc.
BEARISH $1.09B - -7.0% -16.6% $35.67
AMPL
Amplitude, Inc.
BEARISH $982.89M - -32.7% -25.8% $7.35
AXTI
AXT, Inc.
NEUTRAL $943.24M - -9.9% -25.2% $17.4

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2026-02-13 MANNING NEIL President Stock Award 3,749 -
2026-01-30 GUNNING GINA K Officer Stock Award 13,386 -
2025-12-31 MANNING NEIL President Stock Award 1,737 $12,176
2025-12-31 HOSTETLER KEVIN GEORGE Chief Executive Officer Stock Award 3,727 $23,863
2025-12-31 COLLINS TERRANCE L Officer Stock Award 1,156 $10,658
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
23 analysts
Morgan Stanley
2026-03-02
Maintains
Equal-Weight Equal-Weight
JP Morgan
2026-02-26
Maintains
Overweight Overweight
Oppenheimer
2026-02-26
Maintains
Outperform Outperform
RBC Capital
2026-02-26
Maintains
Sector Perform Sector Perform
Deutsche Bank
2026-02-26
down
Buy Hold
Barclays
2026-01-14
Maintains
Equal-Weight Equal-Weight
TD Cowen
2026-01-09
up
Hold Buy
UBS
2025-11-11
Maintains
Buy Buy
Wells Fargo
2025-11-11
Maintains
Equal-Weight Equal-Weight
Seaport Global
2025-11-10
up
Neutral Buy

Past News Coverage

Recent headlines mentioning ARRY from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile